• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

6-(Bromomethyl)-2-chloro-3-cyano-4-(difluoromethyl)pyridine: A Comprehensive Overview

6-(Bromomethyl)-2-chloro-3-cyano-4-(difluoromethyl)pyridine is a highly specialized organic compound with the CAS number 1807024-12-9. This compound belongs to the class of pyridines, which are aromatic heterocyclic compounds widely used in pharmaceuticals, agrochemicals, and materials science. The structure of this compound is characterized by a pyridine ring substituted with multiple functional groups: a bromomethyl group at position 6, a chlorine atom at position 2, a cyano group at position 3, and a difluoromethyl group at position 4. These substituents confer unique chemical properties and reactivity, making it a valuable building block in organic synthesis.

The synthesis of 6-(Bromomethyl)-2-chloro-3-cyano-4-(difluoromethyl)pyridine involves multi-step reactions, often utilizing advanced methodologies such as Suzuki coupling or nucleophilic substitution. Recent studies have highlighted its potential as an intermediate in the development of novel pharmaceutical agents, particularly in the field of oncology and infectious diseases. The compound's ability to act as a precursor for bioisosteric replacements has been extensively explored, offering new avenues for drug design.

One of the most intriguing aspects of this compound is its role in the construction of heterocyclic frameworks. Researchers have demonstrated that 6-(Bromomethyl)-2-chloro-3-cyano-4-(difluoromethyl)pyridine can undergo various cyclization reactions to form complex ring systems, which are essential components of many bioactive molecules. For instance, its participation in enamine formation has been reported to yield compounds with significant antifungal activity.

In terms of applications, this compound has shown promise in the development of advanced materials. Its ability to act as a ligand in metal coordination chemistry has led to the synthesis of novel metal-organic frameworks (MOFs) with potential applications in gas storage and catalysis. Recent findings suggest that these MOFs exhibit exceptional stability under harsh conditions, making them ideal candidates for industrial processes.

The environmental impact and safety profile of 6-(Bromomethyl)-2-chloro-3-cyano-4-(difluoromethyl)pyridine have also been subjects of recent research. Studies indicate that while the compound demonstrates high efficacy in its intended applications, its disposal and handling require careful consideration due to its potential toxicity to aquatic life. Regulatory bodies have recommended stringent guidelines for its use and disposal to minimize environmental risks.

In conclusion, 6-(Bromomethyl)-2-chloro-3-cyano-4-(difluoromethyl)pyridine (CAS No: 1807024-12-9) stands as a testament to the ingenuity of modern organic chemistry. Its versatile structure and diverse applications continue to drive innovation across multiple disciplines. As research progresses, this compound is expected to play an even more pivotal role in advancing both therapeutic development and materials science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)